Research and Development (“R&D”) Expenses : R&D expenses for the three months ended December 31, 2024, were $8.2 million, compared to $13.5 million for the same period in 2023. The decrease was due ...

Ten years of substantial work by Université de Montréal immunologist Nathalie Labrecque's team at the Montreal Clinical ...

B-cell Acute Lymphoblastic Leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it ...

B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most ...

SAN CARLOS, Calif., March 21, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and ...

Background The neutrophil-to-lymphocyte ratio (NLR) is a marker of systemic inflammation associated with adverse ...

Lymphocytes help the body remember and recognize previous invaders if they return to attack again. Lymphocytes begin their life in bone marrow. Some stay in the marrow and develop into B ...

Table 1 Human chemokines and chemokine receptors in lymphocyte traffic: a functional classification into inflammatory (pale green) and homeostatic (dark green) chemokines. Chemokines belonging to ...

A small fraction of the blood-forming cells are blood stem cells. Inside the bone marrow, blood stem cells develop into new blood cells. During this process, the cells become either lymphocytes (a ...